Study of More Than 150,000 People Identifies Genes Strongly Linked to Autism and Neurodevelopmental Disorders
Total of 252 genes cited, providing insights on how mutations might result in developmental disorder and potential targets for treatment
17-Aug-2022 12:10 PM EDT Add to Favorites
Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the...
12-Aug-2022 9:50 AM EDT Add to Favorites
Prompt Recognition and Treatment Found Effective for Lung Disease in Patients Who Received New Drug for Advanced Cancer
Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August...
11-Aug-2022 11:50 AM EDT Add to Favorites
In a study published today in the Journal of General Internal Medicine, researchers at the Icahn School of Medicine at Mount Sinai paint a first-of-its-kind nationally representative portrait of the health care needs of older homebound Americans. An...
10-Aug-2022 10:55 AM EDT Add to Favorites
The Mount Sinai Health System announced today data from an innovative medical-legal pilot program that proactively identifies and provides free, civil legal services to patients in underserved communities who have unaddressed legal needs to improve...
10-Aug-2022 8:00 AM EDT Add to Favorites
Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could...
9-Aug-2022 1:05 PM EDT Add to Favorites
Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need
The Mount Sinai Health System has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company.
9-Aug-2022 9:00 AM EDT Add to Favorites
Icahn School of Medicine at Mount Sinai Announces Biomedical Laureates to Address Health Disparities in Environmental Health, Cancer, and Emergency Medicine
The Icahn School of Medicine at Mount Sinai announced today the appointment of three new Laureates as part of its Biomedical Laureates Program, furthering its institutional commitment to broadening diversity and mentorship opportunities.
9-Aug-2022 8:05 AM EDT Add to Favorites
See All News
13-Jun-2022 3:05 PM EDT
Mount Sinai Experts Share Tips for Ovarian Cancer Awareness Month in September
6-Sep-2019 4:10 PM EDT
Mount Sinai Health System Experts Offer Vital Tips to Detect Early Skin Cancer Prevention and Free Skin Cancer Screenings
23-Apr-2019 2:05 PM EDT
25-Oct-2018 7:05 AM EDT
Mount Sinai Health System Experts Offer New Non-Invasive Imaging Devices to Detect Early Skin Cancer and Vital Tips on Prevention and Screening
20-Apr-2017 4:05 PM EDT
Mount Sinai experts are available during March’s Colorectal Cancer Awareness month to discuss prevention, screening options, and risk factors.
27-Feb-2017 4:05 PM EST
Mount Sinai Health System experts are available for interview at the American Society of Hematology meeting.
2-Dec-2016 11:35 AM EST
28-Jul-2016 10:05 AM EDTSee All Experts